Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Contineum Therapeutics, Inc. - Common stock
(NQ:
CTNM
)
19.64
+0.30 (+1.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Contineum Therapeutics, Inc. - Common stock
Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 06, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences
August 28, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 13, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
July 31, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
June 24, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
June 04, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
June 03, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
May 20, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 16, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.